Yes, challenges remain in balancing accessibility for legitimate medical use against preventing misuse. The black market and illegal production of methamphetamine continue to pose significant challenges to regulators. Additionally, there is a need for continuous monitoring and updating of policies to address emerging patterns of abuse.
